TODARO, Matilde
 Distribuzione geografica
Continente #
NA - Nord America 14.537
EU - Europa 7.391
AS - Asia 5.840
SA - Sud America 879
AF - Africa 178
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 12
Totale 28.849
Nazione #
US - Stati Uniti d'America 14.354
SG - Singapore 2.139
IT - Italia 2.014
RU - Federazione Russa 1.777
CN - Cina 1.395
FI - Finlandia 752
BR - Brasile 694
DE - Germania 641
HK - Hong Kong 619
VN - Vietnam 516
UA - Ucraina 468
GB - Regno Unito 355
PL - Polonia 333
FR - Francia 274
IE - Irlanda 265
BD - Bangladesh 191
JP - Giappone 190
KR - Corea 153
SE - Svezia 141
IN - India 122
CA - Canada 94
NL - Olanda 86
ID - Indonesia 78
BE - Belgio 66
TR - Turchia 64
AR - Argentina 59
MY - Malesia 59
CI - Costa d'Avorio 50
IQ - Iraq 49
MX - Messico 45
RO - Romania 45
AT - Austria 43
EC - Ecuador 35
IR - Iran 31
ZA - Sudafrica 31
VE - Venezuela 28
ES - Italia 27
CZ - Repubblica Ceca 26
UZ - Uzbekistan 26
KE - Kenya 24
SA - Arabia Saudita 23
PK - Pakistan 21
NP - Nepal 19
CL - Cile 18
PH - Filippine 17
CO - Colombia 15
DZ - Algeria 15
PY - Paraguay 15
TH - Thailandia 15
GR - Grecia 14
MA - Marocco 14
KZ - Kazakistan 13
AE - Emirati Arabi Uniti 12
AU - Australia 11
BG - Bulgaria 11
EG - Egitto 11
JO - Giordania 11
TN - Tunisia 11
AZ - Azerbaigian 10
CH - Svizzera 10
KG - Kirghizistan 10
CR - Costa Rica 9
DO - Repubblica Dominicana 8
ET - Etiopia 8
EU - Europa 8
LT - Lituania 7
BH - Bahrain 6
BO - Bolivia 6
HN - Honduras 6
IL - Israele 6
OM - Oman 6
HU - Ungheria 5
LB - Libano 5
PE - Perù 5
PT - Portogallo 5
TW - Taiwan 5
GT - Guatemala 4
JM - Giamaica 4
KW - Kuwait 4
MD - Moldavia 4
NG - Nigeria 4
PA - Panama 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
GE - Georgia 3
HR - Croazia 3
LV - Lettonia 3
QA - Qatar 3
RS - Serbia 3
SV - El Salvador 3
A1 - Anonimo 2
AL - Albania 2
AM - Armenia 2
AO - Angola 2
DK - Danimarca 2
EE - Estonia 2
LU - Lussemburgo 2
SN - Senegal 2
Totale 28.824
Città #
Ashburn 1.769
Fairfield 1.750
Singapore 1.481
Woodbridge 895
Chandler 882
Houston 748
Seattle 674
San Jose 657
Ann Arbor 642
Wilmington 635
Cambridge 627
Palermo 594
Hong Kong 591
Moscow 331
Zgierz 290
Council Bluffs 265
Dublin 264
Jacksonville 254
New York 235
Beijing 213
Los Angeles 208
Santa Clara 203
Medford 199
Helsinki 187
The Dalles 185
Des Moines 179
Tokyo 178
Ho Chi Minh City 172
Dallas 163
Boardman 162
Hefei 141
Altamura 134
Frankfurt am Main 132
Lauterbourg 132
Princeton 131
Hanoi 130
San Diego 128
Nanjing 123
Milan 114
Lawrence 111
Rome 95
Dearborn 84
Buffalo 81
London 79
Chicago 77
Tulsa 72
São Paulo 66
Ludwigshafen am Rhein 60
Brussels 57
Munich 53
Jakarta 52
Abidjan 49
Seoul 49
Phoenix 48
Nuremberg 45
Orem 45
Nanchang 43
Berlin 40
Kuala Selangor 39
Amsterdam 38
Changsha 35
Tianjin 34
Shenyang 33
Stockholm 32
Guangzhou 31
Seongnam 31
Columbus 29
Warsaw 29
Bremen 28
Brooklyn 28
Hebei 28
Izmir 28
Kumar 28
Paris 28
Montreal 27
Naples 27
Denver 26
Jinan 26
Da Nang 25
Lappeenranta 25
Rio de Janeiro 24
Venice 24
Baghdad 23
Chennai 23
Jiaxing 23
San Paolo di Civitate 23
Falls Church 22
Shanghai 22
Tashkent 22
Vienna 22
Haiphong 21
Nairobi 20
Poplar 20
Saint Petersburg 20
Turku 20
City of London 18
Atlanta 17
Catania 17
Olomouc 17
Redwood City 17
Totale 19.074
Nome #
CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis 480
High Levels of Exogenous C2-Ceramide Promote Morphological and Biochemical Evidences of Necrotic Features in Thyroid Follicular Cells 394
IL4 primes the dynamics of breast cancer progression via DUSP4 inhibition 345
Comparative study of T84 and T84SF human colon carcinoma cells: in vitro and in vivo ultrastructural and functional characterization of cell culture and metastasis 331
Activated thyroid hormone promotes differentiation and chemotherapeutic sensitization of colorectal cancer stem cells by regulating Wnt and BMP4 signaling 330
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4 327
Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4 309
Colon Cancer Stem Cells: Bench-to-Bedside—New Therapeutical Approaches in Clinical Oncology for Disease Breakdown 301
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells 301
Squamous cell tumors recruit γδ T cells producing either IL17 or IFNγ depending on the tumor stage 300
Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas 299
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant 294
Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells 293
Distinctive features of tumor-infiltrating gd T lymphocytes in human colorectal cancer 286
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway 285
MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state 282
Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities 281
Tumor and its microenvironment: a synergistic interplay. 278
A BMP7 variant inhibits tumor angiogenesis in vitro and in vivo through direct modulation of endothelial cell biology 276
Colorectal cancer defeating? Challenge accepted! 268
MUC1 Oncoprotein Promotes Refractoriness to Chemotherapy in Thyroid Cancer Cells 266
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin 262
By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy 259
Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells. 256
Survivin is regulated by interleukin-4 in colon cancer stem cells 255
OSSERVAZIONi A PROPOSITO DI UN CASO DI CISTI GIGANTE DELLA MILZA 246
CANCER STEM CELLS CONTRIBUTE TO THE AGGRESSIVE BEHAVIOUR OF HUMAN EPITHELIAL COLON CANCER. 245
Nobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy 245
Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis. 243
PED Mediates AKT-Dependent Chemoresistance in Human Breast Cancer Cells 242
Normal vs cancer thyroid stem cells: the road to transformation 242
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 240
ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis 239
Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy 237
Erythropoietin activates cell survival pathways in breast cancer stem-like cells to protect them from chemotherapy 236
Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study. 236
Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes 234
Immunotherapy targeting colon cancer stem cells 234
Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. 232
Colorectal Cancer Stem Cells: From the Crypt to the Clinic 231
Cancer cell targeting by CAR-T cells: A matter of stemness 228
Innovative Therapeutic Strategies Targeting Colorectal Cancer Stem Cells 227
Meeting the Challenge of Targeting Cancer Stem Cells 226
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells 225
Isolation and culture of colon cancer stem cells. 225
Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment 224
INTRODUCING NON-ADHERENT PROGENITORS FROM ADIPOSE-DERIVED STEM CELLS (NAPADSCS): PROOF OF STEMNESS AND POSSIBLE FUTURE APPLICATIONS IN REGENERATIVE SURGERY 224
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells 223
C1Q+ TPP1+ macrophages promote colon cancer progression through SETD8-driven p53 methylation 222
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 219
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51 219
Lipid droplets: A New Player in Colorectal Cancer Stem Cells Unveiled by Spectroscopic Imaging 217
Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis 216
Autocrine production of IL-4 confers resistance to chemotherapy and CD-95 induced cell death in cancer cells. 215
Differentiation, phenotype, and function of interleukin-17-producing human V{gamma}9V{delta}2 T cells 215
ADHESION AND OSTEOGENIC DIFFERENTIATION OF NON-ADHERENT PROGENITORS FROM ADIPOSE-DERIVED STEM CELLS (napASCs) OVER INTEGRA DERMAL REGENERATION TEMPLATE 214
Therapeutic implications of Cancer Initiating Cells. 211
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 211
Estrogens and stem cells in thyroid cancer 207
Mechanisms underlying lineage commitment and plasticity of human γδ T cells. 207
V{gamma}9V{delta}2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells. 206
Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy 206
γδ T cells as a potential tool in colon cancer immunotherapy 205
Tumorigenic and metastatic activity of human thyroid cancer stem cells 205
A Novel Tumor on Chip Mimicking the Breast Cancer Microenvironment for Dynamic Drug Screening 204
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. 203
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 203
Colon cancer stem cells: promise of targeted therapy. 200
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b 199
Microenvironment in neuroblastoma: Isolation and characterization of tumor-derived mesenchymal stromal cells 197
ANTIBODY SPECIFIC FOR HUMAN IL-4 FOR THE TREAMENT OF CANCER 196
Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme 196
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells 196
IL-4-mediated drug resistance in colon cancer stem cells 195
Erratum: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy 195
Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules 194
Apoptosis induced by a HIPK2 full-length-specific siRNA is due to off-target effects rather than prevalence of HIPK2-Δe8 isoform. 191
CD133 as a target for colon cancer. 190
Heightened IDO1 levels predict Bacillus Calmette-Guèrin failure in high-risk non-muscle-invasive bladder cancer patients 189
Cancer-Initiating Cells from Colorectal cancer Patients Escape from T Cell-Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 188
Galectin-3 immunodetection for improving the performance of conventional thyroid cytology: preliminay results 187
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells 187
Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells. 185
Prevention of Chemotherapy-Induced Anemia and Thrombocytopenia by Constant Administration of Stem Cell Factor 182
Involvement of caspase-3 and GD3 ganglioside in ceramide-induced apoptosis in Farber disease 182
Colorectal cancer stem cells and cell death 182
IL-21 regulates the differentiation of a human γδ T cell subset equipped with B cell helper activity. 180
Role of interleukin-4 on colon cancer stem cell survival 179
Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer 178
Metodo per la purificazione e l’ampliamento di cellule staminali tumorali 176
Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vγ9Vδ2 T Cell-Mediated Cytotoxicity 175
Identification and expansion of human colon-cancer-initiating cells. 173
Crucial role of interleukin-4 in the survival of colon cancer stem cells 171
Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers 171
ROS and Lipid Droplet accumulation induced by high glucose exposure in healthy colon and Colorectal Cancer Stem Cells 171
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. 170
Role of Type I and II interferons in colorectal cancer and melanoma 168
Thyroid Cancer Resistance to Chemotherapeutic Drugs via Autocrine Production of Interleukin-4 and Interleukin-10 165
Protocol for generation and engineering of thyroid cell lineages using CRISPR-Cas9 editing to recapitulate thyroid cancer histotype progression 164
DOWN REGULATION OF LYMPHOCYTES APOPTOSIS IN GIRLS WITH PRECOCIOUS PUBERTY 164
Totale 22.983
Categoria #
all - tutte 98.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.999


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021191 0 0 0 0 0 0 0 0 0 0 0 191
2021/20222.086 107 403 78 62 130 75 117 108 242 258 161 345
2022/20232.547 228 449 50 322 268 442 161 168 270 31 108 50
2023/20241.179 64 153 76 63 92 244 128 82 19 30 21 207
2024/20253.253 93 230 202 254 112 106 230 239 198 422 435 732
2025/202611.049 851 292 659 839 1.048 1.643 1.559 1.037 900 1.366 569 286
Totale 29.698